QQ客服 官方微博 反馈留言

	Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention
	Bai, Xiao-Fang; Zhang, Ya-Ping; Zhou, Juan; Wu, Yue; Li, Rui-Feng; Sun, Li-Zhe; Ma, Qiang-Qiang; Lou, Bo-Wen; Zhai, Bo-Wen; Liu, Meng-Ping
刊名	THROMBOSIS RESEARCH
	2018
卷号	Vol.170页码:142-147
关键词	Acute coronary syndrome CYP2C19 metabolizer GRACE score Risk factor Prognosis
ISSN号	0049-3848
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5465665
专题	湖南大学
作者单位	1.Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Cardiovasc Med,Dept Ultrasound Imaging, Xian 710061, Shaanxi, Peoples R China 2.Xian 3.Hosp, Jie Fang Rd, Xian 710004, Shaanxi, Peoples R China 4.Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Lab, Xian, Shaanxi, Peoples R China 5.Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China
推荐引用方式 GB/T 7714	Bai, Xiao-Fang,Zhang, Ya-Ping,Zhou, Juan,et al. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention[J]. THROMBOSIS RESEARCH,2018,Vol.170:142-147.
APA	Bai, Xiao-Fang.,Zhang, Ya-Ping.,Zhou, Juan.,Wu, Yue.,Li, Rui-Feng.,...&Liu, Meng-Ping.(2018).Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.THROMBOSIS RESEARCH,Vol.170,142-147.
MLA	Bai, Xiao-Fang,et al."Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention".THROMBOSIS RESEARCH Vol.170(2018):142-147.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。